The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
ADCT · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | ADCT | INSP | BIO | CDRE |
|---|---|---|---|---|
| Moat Score (0–100) | 55 (highest) | 55 (highest) | 55 (highest) | 55 (highest) |
| Methodology version | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 |
| Business trend | 42 | 82 (highest) | 77 | 55 |
| Pricing power | 100 (highest) | 99 | 92 | 68 |
| Returns on capital | — | 0 | 0 | 52 (highest) |
| Balance-sheet safety | 55 | 73 (highest) | 12 | 71 |
| Capital discipline | 24 | 24 | 96 (highest) | 28 |
| Price vs. high estimate | No price data | No price data | No price data | 136% above high estimate |
| Market cap | $158.4M | $1.5B | $8.2B | $1.2B |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |